Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 2:31 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1753–1776 of 21,991 matching trials from the live ClinicalTrials.gov search.

Filters: Recruiting Clear all

Conditions: Race-related Stress, Depression, Anxiety, Quality of Life, Stress Reaction
Interventions: ACT for SCD; Behavioral
Lead sponsor: Children's Hospital Los Angeles; Other
Eligibility: 14 Years to 21 Years
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Postoperative Atrial Fibrillation
Interventions: Amiodarone Injection, Intraoperative Rapid Atrial Pacing; Drug · Device
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 600 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2050
U.S. locations: 1
States / cities: Stanford, California

Conditions: Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm
Interventions: Discussion, Goal Setting, Interview, Media Intervention, Medical Device Usage and Evaluation, Questionnaire Administration, Reward, Text Message-Based Navigation Intervention; Other
Lead sponsor: Children's Oncology Group; Network
Eligibility: 15 Years to 20 Years
Enrollment: 190 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 76
States / cities: Mesa, Arizona • Phoenix, Arizona • Little Rock, Arkansas + 58 more

Conditions: Diabetic Retinopathy
Interventions: Blood draw; Other
Lead sponsor: Indiana University; Other
Eligibility: 18 Years and older
Enrollment: 192 participants
Timeline: 2022 – 2027
U.S. locations: 3
States / cities: Carmel, Indiana • Indianapolis, Indiana

Conditions: Oneida Nation Members
Interventions: Health Wellness Coaching, Carotid ultrasound, School-age nutritional education program, Cognitive Testing, Blood work; Behavioral · Diagnostic Test
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 7 Years to 85 Years
Enrollment: 95 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 2
States / cities: Madison, Wisconsin • Oneida, Wisconsin

Conditions: Hemodialysis
Interventions: "Move More" Personalized Exercise Program, Intradialytic Exercise Program; Behavioral
Lead sponsor: University of Arizona; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Obsessive-Compulsive Disorder
Interventions: Cognitive bias modification for interpretation bias, Psychoeducation; Behavioral
Lead sponsor: Mclean Hospital; Other
Eligibility: 18 Years and older
Enrollment: 106 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Belmont, Massachusetts

Conditions: Overweight and Obesity, Metabolic Syndrome
Interventions: Control, Overfeeding; Behavioral
Lead sponsor: Pennington Biomedical Research Center; Other
Eligibility: 18 Years to 42 Years
Enrollment: 58 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2026
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Plasma Cell Myeloma, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma, Smoldering Plasma Cell Myeloma
Interventions: Behavioral Intervention, Beta-Adrenergic Antagonist, Propranolol, Quality-of-Life Assessment, Questionnaire Administration, Resistance Training, Short-Term Fasting; Behavioral · Drug · Other
Lead sponsor: Roswell Park Cancer Institute; Other
Eligibility: 18 Years and older
Enrollment: 175 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Colorectal Cancer, Pancreatic Cancer
Interventions: Irinotecan; Drug
Lead sponsor: Reema A. Patel; Other
Eligibility: 18 Years and older
Enrollment: 178 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Mixed Fiber Supplementation for Healthy Adults
Interventions: Prebiotic, Placebo; Dietary Supplement
Lead sponsor: Brown University; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Chronic Pseudomonas Aeruginosa Infection, Cystic Fibrosis (CF)
Interventions: BX004, Placebo; Biological · Other
Lead sponsor: BiomX Ltd; Industry
Eligibility: 18 Years and older
Enrollment: 63 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 14
States / cities: Birmingham, Alabama • Anchorage, Alaska • Little Rock, Arkansas + 11 more

Conditions: Pregnancy, High Risk, Type 1 Diabetes
Interventions: Insulin, DEXCOM Continuous Glucose Monitor; Drug · Device
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Postoperative Pain, Opioid Use
Interventions: Pain, Opioid use; Behavioral
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 11 Years to 16 Years · Female only
Enrollment: 210 participants
Timeline: 2023 – 2029
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Chronic Granulomatous Disease, Infection
Interventions: gp91 Grans; Biological
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 75 Years · Male only
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Atopic Dermatitis
Interventions: APG777; Drug
Lead sponsor: Apogee Therapeutics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 350 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 23
States / cities: Fountain Valley, California • Los Angeles, California • Coral Gables, Florida + 20 more

Conditions: Pain, Postoperative, Postoperative Pain, Acute
Interventions: Acetaminophen, Celecoxib, Gabapentin; Drug
Lead sponsor: Northwell Health; Other
Eligibility: Female only
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Bay Shore, New York

Conditions: Spinal Cord Injuries, Endothelial Dysfunction, Testosterone Deficiency
Interventions: Intra-arterial Infusion of Vasoactive Agents, Intra-arterial Vitamin C Infusion, Blood Sampling; Diagnostic Test
Lead sponsor: Craig Hospital; Other
Eligibility: 18 Years to 89 Years · Male only
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Englewood, Colorado

Conditions: Esophageal Motility Disorders, Achalasia
Interventions: Not listed
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Heart Failure, Polygenic Score
Interventions: Beta blocker; Other
Lead sponsor: David Lanfear; Other
Eligibility: 18 Years to 89 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Type 2 Diabetes Mellitus, T2DM
Interventions: HM15275, Placebo of HM15275; Drug
Lead sponsor: Hanmi Pharmaceutical Company Limited; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 20
States / cities: Mesa, Arizona • Santa Clarita, California • DeLand, Florida + 14 more

Conditions: Viral Lung Infection and Acute Respiratory Failure
Interventions: Tozorakimab, Placebo; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years and older
Enrollment: 3,527 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 75
States / cities: Birmingham, Alabama • Mobile, Alabama • Phoenix, Arizona + 67 more

Conditions: Tic Disorders
Interventions: Comprehensive Behavioral Intervention for Tics (CBIT); Behavioral
Lead sponsor: University of Miami; Other
Eligibility: 5 Years to 17 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Coral Gables, Florida

Conditions: Total Knee Arthroplasty
Interventions: IO Administration of Cefazolin, IO Administration of Vancomycin, IV Administration of Cefazolin, IV Administration of Vancomycin; Drug
Lead sponsor: The Methodist Hospital Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2035
U.S. locations: 1
States / cities: Houston, Texas

Search by objective public record fields.

Acceptance and Commitment Therapy for Adolescents and Young Adults With Sickle Cell Disease

Prevention of Postop Atrial Fibrillation Through Intraoperative Inducibility of Atrial Fibrillation and Amiodarone Treatment

A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention for Improving Physical Activity in Hispanic or Latino/Latina Adolescent and Young Adult Childhood Cancer Survivors, Walking Juntos Study

Biomarker of Diabetic Retinopathy

The AHA Oneida Study

Physical Activity Prescription Program for Hemodialysis Patients

Interpretation Bias as a Mechanism of Treatment Response in OCD

Testing the Adipose Expandability Hypothesis In Vivo During Overfeeding

Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma

GENOCARE: A Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care

Assessing the Short-Term Effects of Multi-Fiber Supplementation on Gut Health

Study With Phage for CF Subjects With Pseudomonas Lung Infection

Permissive Versus Strict Intrapartum Glucose Management in Type 1 Diabetes (PRISM-T1D)

Sex Hormones, Postoperative Pain and Opioid Use

NADPH Oxidase Correction in mRNA-transfected Granulocyte-enriched Cells in Chronic Granulomatous Disease (CGD)

A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis

Impact of Preoperative Opioid-free Multimodal Analgesia on Time to Trial of Void in Ambulatory Urogynecologic Surgeries

Testosterone Deficiency and Endothelial Dysfunction After Spinal Cord Injury

Clinical Outcomes, Safety, and Effectiveness of Speedboat UltraSlim™ in Per-Oral Endoscopic Myotomy (POEM)

UPBEAT: Using Polygenic Scores to Guide BB Therapy in HF With Mildly Reduced EF

Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus

Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen

Comprehensive Behavioral Intervention for Tics

Intraosseous (IO) Cefazolin and Vancomycin in Primary Total Knee Arthroplasty (TKA)